From Sample to Insight: Technologies Driving the Future of Precision Oncology Assays
Steps to biomarker-driven targeted cancer therapy to improve patient outcomes. Image adapted from: American Cancer Society Cancer Action Network. (2020, September 28). Improving access to biomarker testing: Advancing precision medicine in cancer care. Retrieved June 23, 2025, from https://www.fightcancer.org/policy-resources/improving-access-biomarker-testing
• Ensuring diagnostic insights are within electronic medical records and care team communications 10 • Building infrastructure for repeat testing, including reimbursement pathways and lab access, to support dynamic testing at multiple time points 11 Ultimately, a more fluid and connected approach to cancer care enables clinicians to anticipate, adapt, and personalize treatment continuously— rather than responding in isolated episodes. It also empowers patients by aligning clinical decisions with the evolving biology of their disease, ensuring that precision medicine delivers on its full promise. As biomarkers take on an increasingly central role in guiding cancer diagnosis and treatment, it’s the enabling technologies behind them that make true precision possible. Scientists at
Meridian have spent years working closely with assay developers to address the technical chal- lenges of implementing biomarker testing in real-world clinical settings. Through this collab- oration, they’ve developed inhibitor-tolerant qPCR mixes that help reduce turnaround times by minimizing sample prep and enabling direct amplification from complex clinical matrices. Meridian’s team has also pioneered stabilization technologies—supporting room-temperature storage and transport for reagents that would traditionally require cold-chain logistics. These innovations help ensure molecular tests remain robust, scalable, and accessible wherever and whenever they are needed most. View our catalog on Specimen-specific™ Inhib- itor Tolerant qPCR & LAMP Master Mixes for Ultra-Sensitive Detection to learn more about our solutions. n
10 | GENengnews.com
Powered by FlippingBook